Antiretroviral therapy and viral suppression among active duty service members with incident HIV infection - United States, January 2012-June 2018

Shauna Stahlman; Shilpa Hakre; Paul T. Scott; Brian K. Agan; Donald Shell; Todd Gleeson; Jason M. Blaylock; Jason F. Okulicz

doi:10.15585/MMWR.MM6913A2

Antiretroviral therapy and viral suppression among active duty service members with incident HIV infection - United States, January 2012-June 2018

Shauna Stahlman^*, Shilpa Hakre, Paul T. Scott, Brian K. Agan, Donald Shell, Todd Gleeson, Jason M. Blaylock, Jason F. Okulicz

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

What is already known about this topic? U.S. Department of Defense (DoD) service members with human immunodeficiency virus (HIV) infection can remain in military service; however, treatment outcomes have not been fully described. What is added by this report? During January 2012-June 2018, 93.8% of service members with HIV infection who remained in care received continuous antiretroviral therapy (ART). Viral suppression was achieved in 99.0% within 1 year of ART initiation and in 96.8% at the last test during the surveillance period. What are the implications for public health practice? The DoD model of HIV care demonstrates that the goals of high ART uptake and viral suppression can be achieved and maintained in a large health care system.

Original language	English
Pages (from-to)	366-370
Number of pages	5
Journal	Morbidity and Mortality Weekly Report
Volume	69
Issue number	13
DOIs	https://doi.org/10.15585/MMWR.MM6913A2
State	Published - 3 Apr 2020

Access to Document

10.15585/MMWR.MM6913A2

Cite this

@article{d5e0ffcedb5249faa708c30a49e2e70c,

title = "Antiretroviral therapy and viral suppression among active duty service members with incident HIV infection - United States, January 2012-June 2018",

abstract = "What is already known about this topic? U.S. Department of Defense (DoD) service members with human immunodeficiency virus (HIV) infection can remain in military service; however, treatment outcomes have not been fully described. What is added by this report? During January 2012-June 2018, 93.8% of service members with HIV infection who remained in care received continuous antiretroviral therapy (ART). Viral suppression was achieved in 99.0% within 1 year of ART initiation and in 96.8% at the last test during the surveillance period. What are the implications for public health practice? The DoD model of HIV care demonstrates that the goals of high ART uptake and viral suppression can be achieved and maintained in a large health care system.",

author = "Shauna Stahlman and Shilpa Hakre and Scott, {Paul T.} and Agan, {Brian K.} and Donald Shell and Todd Gleeson and Blaylock, {Jason M.} and Okulicz, {Jason F.}",

year = "2020",

month = apr,

day = "3",

doi = "10.15585/MMWR.MM6913A2",

language = "English",

volume = "69",

pages = "366--370",

journal = "Morbidity and Mortality Weekly Report",

issn = "0149-2195",

publisher = "Centers for Disease Control and Prevention",

number = "13",

}

TY - JOUR

T1 - Antiretroviral therapy and viral suppression among active duty service members with incident HIV infection - United States, January 2012-June 2018

AU - Stahlman, Shauna

AU - Hakre, Shilpa

AU - Scott, Paul T.

AU - Agan, Brian K.

AU - Shell, Donald

AU - Gleeson, Todd

AU - Blaylock, Jason M.

AU - Okulicz, Jason F.

PY - 2020/4/3

Y1 - 2020/4/3

N2 - What is already known about this topic? U.S. Department of Defense (DoD) service members with human immunodeficiency virus (HIV) infection can remain in military service; however, treatment outcomes have not been fully described. What is added by this report? During January 2012-June 2018, 93.8% of service members with HIV infection who remained in care received continuous antiretroviral therapy (ART). Viral suppression was achieved in 99.0% within 1 year of ART initiation and in 96.8% at the last test during the surveillance period. What are the implications for public health practice? The DoD model of HIV care demonstrates that the goals of high ART uptake and viral suppression can be achieved and maintained in a large health care system.

AB - What is already known about this topic? U.S. Department of Defense (DoD) service members with human immunodeficiency virus (HIV) infection can remain in military service; however, treatment outcomes have not been fully described. What is added by this report? During January 2012-June 2018, 93.8% of service members with HIV infection who remained in care received continuous antiretroviral therapy (ART). Viral suppression was achieved in 99.0% within 1 year of ART initiation and in 96.8% at the last test during the surveillance period. What are the implications for public health practice? The DoD model of HIV care demonstrates that the goals of high ART uptake and viral suppression can be achieved and maintained in a large health care system.

UR - http://www.scopus.com/inward/record.url?scp=85083003195&partnerID=8YFLogxK

U2 - 10.15585/MMWR.MM6913A2

DO - 10.15585/MMWR.MM6913A2

M3 - Article

C2 - 32240126

AN - SCOPUS:85083003195

SN - 0149-2195

VL - 69

SP - 366

EP - 370

JO - Morbidity and Mortality Weekly Report

JF - Morbidity and Mortality Weekly Report

IS - 13

ER -

Antiretroviral therapy and viral suppression among active duty service members with incident HIV infection - United States, January 2012-June 2018

Abstract

Access to Document

Fingerprint

Cite this